KCM
SCPH

Kennedy Capital Management’s scPharmaceuticals SCPH Stock Holding History

Kennedy Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-218,812
Closed -$952K – 728
2024
Q2 		$952K Sell
218,812
-942
-0.4% -$4.14K 0.02% 594
2024
Q1 		$1.1M Sell
219,754
-3,246
-1% -$18.2K 0.02% 614
2023
Q4 		$1.4M Sell
223,000
-3,604
-2% -$20.6K 0.03% 547
2023
Q3 		$1.61M Hold
226,604
– – 0.04% 496
2023
Q2 		$2.31M Hold
226,604
– – 0.05% 432
2023
Q1 		$2.06M Hold
226,604
– – 0.06% 397
2022
Q4 		$1.62M Buy
+226,604
New +$1.38M 0.05% 436

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return